▲ The HERA W10 Elite features an ergonomic-friendly design and is optimized with updated imaging capabilities to drive diagnostic confidence.

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, introduces the HERA W10 Elite,¹ the premier model of the HERA platform for Obstetrics and Gynecology that provides clinicians with a suite of powerful artificial intelligence (AI) tools and clinical applications to advance the diagnostic experience.

“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to Obstetrics and Gynecology with sophisticated image processing and an ergonomic-friendly design,” said Tracy Bury, Women’s Health Ultrasound Business Leader, Boston Imaging.

The HERA W10 Elite may assist clinicians in receiving greater insight in diagnosis with its intuitive visualizations, precise analytic features and fast operation. The revolutionized system has also been updated from its predecessor in a variety of aspects, including:

• Advanced MV-Flow: To display the intensity of blood flow, it provides 2D and 3D visualization of microcirculatory and slow blood.
• Larger OLED Display: The display area has been increased by 57%,² while the OLED³ screen realistically represents black colors making it well-suited for diverse ultrasound image characteristics.
• New Transducer: The EV2-12⁴ allows visualization of the fetal heart and brain starting at eight weeks endovaginally.

The system is also equipped with enhanced AI features, such as:

• HeartAssist: Provides measurement results and automatically classifies an ultrasound image into measurement views required for fetal heart diagnosis.
• ViewAssist: Automatically classifies ultrasound images and annotates the structures for convenient measurement (16 new views added). ^4,5
• BiometryAssist: Enables clinicians to measure fetal growth parameters with a single click while maintaining exam consistency.⁴

Samsung is committed to bringing new and updated women’s health-focused ultrasound systems to market to remain true to its pledge to support the life-long healthcare of women. The HERA W10 Elite will be showcased at the Society for Maternal Fetal Medicine’s 43rd Annual Pregnancy Meeting from February 8 to 10 at booth #317.

Additional information on the system can be found here.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

¹ Elite is not a product name but is a marketing terminology.

² Compared to Samsung HERA W10

³ OLED: Organic Light-Emitting Diode

⁴ The hardware and software features are FDA 510(k) pending, not available for sale in United States.

⁵ ViewAssist fully covers global guidelines from 1st to 3rd trimester.

▲ Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting.

Samsung Electronics will be unveiling its latest artificial intelligence (AI) technologies and presenting its premium diagnostic solutions in ultrasound, digital radiography (DR) and mobile computed tomography (CT) at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting from November 27 to December 1.

David Legg, Vice President, Head of Business, Boston Imaging, a subsidiary of Samsung, shares, “Samsung has a long-standing history of leading the charge in technology advancements – 2022 has been a testament to this as we have worked to redefine our cutting-edge solutions across modalities. We’re now deploying real-time on-device AI technology to help healthcare professionals examine and diagnose patients with ease and accuracy from the start.”

Samsung has remained focused on the critical clinical needs that elevate customer experience when developing new products. During the conference, the company will highlight 2022 achievements that worked to make the world a healthier place by empowering clinicians to diagnose their patients more confidently.

“Innovation is at the core of Samsung’s business. We take great pride in delivering our customers’ leading-edge technology on all Samsung devices,” said Kyu Tae Yoo, Senior Vice President, Global Head of Sales and Marketing, Samsung Medison. “As we look to expand diagnostic possibilities and improve the clinical experience that our customers need, we will keep healthcare professionals and the patients they treat top of mind.”

Additional details about the novel innovations Samsung will showcase during the conference can be found below.

Ultrasound

At the event, Samsung will showcase leading product updates, including the V7 ultrasound system, a new endocavity transducer and new real-time on-device AI solutions.

The new on-device AI solution for ultrasound, known as HeartAssist, which can enhance the diagnosis and examination process, will be on display. It’s a deep learning-based function that automatically finds the cross-section of the heart and measures different points needed for an accurate diagnosis. The automated nature allows for a streamlined workflow due to fewer keystrokes. The feature can be found on the V8 and V7 ultrasound systems.

Samsung also recently released the new V7 ultrasound system, which provides a wide array of clinical applications, including a range of on-device Intelligent Assist features such as BiometryAssist and UterineAssist, that enhance both the patient and user experience.

From general imaging to women’s health, it was designed to deliver a multi-faceted diagnostic experience. Crystal Architecture is the core of the V7’s enhanced image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The miniER7,¹ a new endocavity transducer, will be shown alongside the V7 ultrasound system. With a radius size of 7mm — 3mm smaller than the existing probe — the new probe was designed to ease the burden felt by healthcare professionals as well as the discomfort that patients often experience during prostate ultrasound scanning. The miniER7 was created with state-of-the-art micro-processing technology to capture clear images at a reduced file size.

Digital Radiography

Samsung is also showcasing its premium digital radiography solutions, including the new “Vision Assist” solution and AccE Glass Free Detector.

The AccE GC85A Vision² premium ceiling digital radiography system with “Vision Assist” provides more enhanced patient care and workflow efficiency maintaining an advanced low-dose imaging experience. Specifically, the AccE GC85A Vision focuses on new ways to increase efficiencies so healthcare professionals can streamline without compromising, including:

• Reduced Operation Time: The Intelligent Collimation and Stitching Auto Planning features provide the optimal collimated area automatically with just one click using deep learning technology. While the Patient Size Guide recommends patient size and optimal parameters based on the patient’s body thickness to save time.³
• Decreased Retake Error: The Virtual Overlay feature displays a virtual drawing of the receptor boundary and AEC chamber onto the patient to help the operator with patient positioning. The Motion Alarm based on machine learning technology can inform the operator of patient movements and falls. Virtual Collimation then allows the operator to make adjustments to the collimated area from the control room with ease.³
• Continuous Patient Care: The operator can continuously monitor the patient through Vision Live, which is a live camera in the tube head unit.

With a strategic focus on workflow optimization, Samsung also recently released a new flagship detector, the AccE Glass-Free Detector, which offers a more comfortable imaging experience without compromising image quality. Designed to deliver high-resolution images of a lightweight digital detector, it provides additional user and patient benefits, including:

• Functionality: It boasts a non-glass flexible panel with center-engraving to position a patient, a side chamfer to ease lifting and a rear grip to support transportation. It also weighs 27% lighter than the conventional model⁴ (approximately 4.5 pounds).⁵
• Reliability: Its high load allowance (up to 881 pounds of surface load and 441 pounds of patient load)⁶ and dust and water-resistant design allows for reduced user concern in complex environments like the ER and OR.
• Clear Visibility: It exhibits a 76% DQE, leading the market in glassless panel technology.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite with Photon Counting Detector (PCD) technology and BodyTom^® 64.

The state-of-the-art OmniTom^® Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. With the addition of PCD technology, the system provides the ability to capture CT data in multiple energy bands. The multiple sets of CT data are acquired at the same time with configurable energy thresholds without any cross talk between images. The PCD system⁷ brings multi-energy CT functionality with spectral capability for material decomposition, virtual monoenergetic images (VMI) and soft tissue identification.

The BodyTom^® 64 is an upgraded version of the BodyTom^® Elite CT scanner, providing enhanced functionality with high-resolution imaging capabilities. The head-to-toe trauma imaging solution boasts revisions based on customer feedback, with indications for both pediatric and adult imaging and can be used for low dose lung cancer screening. The BodyTom^® 64 is a multi-departmental imaging solution that can be utilized in neurosurgery, interventional radiology, brachytherapy, trauma, medical examination and more.

Environmental, Social and Governance

Samsung not only focuses on advancing its diagnostic solutions and technologies, but also takes part in protecting the environment by developing eco-friendly packages as a part of its environmental, social and governance management.

Expanded Polyethylene foam (EPE) foams that were previously used in the ultrasound packages were replaced by recycled papers, resulting in the reduction of 15 tons of EPE foams in 2022. Samsung’s goal is “Zero” usage of EPE foams by 2023. In addition, polyurethane materials that were used for transducer packages are also being replaced by recycled papers, expecting to reduce the usage of polyurethane to 8 tons.

Visit Samsung at Booth # 2165. To learn more about the Samsung products on display and other events visit: https://samsunghealthcare.com/en/rsna2022.

About Boston Imaging

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https://www.bostonimaging.com/.

About NeuroLogica

NeuroLogica Corp., the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica is the global corporate headquarters and manufacturer of mobile computed tomography devices. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit: http://www.neurologica.com.

¹ miniER7: Pending FDA 510(k) clearance, not available for sale within the United States

² The AccE GC85A Vision is a sub configuration of The AccE GC85A

³ Compared to the current AccE GC85A configuration, without a camera solution

⁴ Compared to S4335-AW

⁵ Measured without battery set

⁶ Based on 40 mm diameter disc at the center

⁷ OmniTom^® Elite with PCD: Pending FDA 510(k) clearance, not available for sale within the United States

During this congress, Samsung will be showcasing the clinical values and efficiencies of the Artificial Intelligence (AI)-based diagnostic solutions through various scientific programs.

Samsung’s symposium will be held on September 18^th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions: BiometryAssist which measures the growth and condition of a fetus and HeartAssist which improves workflow when diagnosing a fetal heart.

Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSync, a real-time ultrasound image-sharing solution during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome from the ISUOG venue in London.

“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in ultrasound environment using SonoSync brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”

In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high performance diagnostic solutions such as MV-Flow which is used to visualize the slow flow of microvascular structures and the existence of micro-blood-flow.

The onsite scientific programs, Samsung will display online webinars at six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and the Samsung’s Healthcare website (www.samsunghealthcare.com).

Samsung will also showcase its premium ultrasound system for obstetrics and gynecology known as HERA W10 and V8 which systems includes Intelligent Assist (AI diagnostic solutions), as well as V7, high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.

As far as the name, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology and more. The V7 hosts features and solutions seen on premium ultrasound systems.

※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.

Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison stated “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals. We will continuously proceed forward introducing diagnostic solutions for the medical professionals and patients.”

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Exhibition products at ISUOG 2022 (from left — V7, HERA W10, V8)

SonoSync — Solution to overcome spatial constraints when performing ultrasound exams

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

Examinations for women with high risk pregnancy, early diagnosis of fetal abnormalities, and automatic measurement solutions in ultrasound for delivery—quality healthcare solutions enabled by Samsung Medison—have been acknowledged and noted in the medical profession.

The devices will be showcased on an online platform prepared for the virtual event, which will feature webinars, virtual exhibitions and chat tools. Samsung Medison will display its new HERA series of ultrasound devices (HERA W10, HERA I10, HERA W9) featuring its new advanced technologies and solutions. The various Intelligent Assist solutions, elaborating on the details will be presented in a video format.

The solutions which expand across the full spectrum of diagnostic functions and capabilities include the following:

• BiometryAssist – Measures the fetal growth index quickly and confidently with the view that has been acquired semi-automatically.
• HeartAssist¹ – Helps to measure and provide a suitable guideline view for an early finding of congenital heart abnormalities for the fetus before it is born, utilizing deep learning.
• LaborAssist – Allows easy discovery of changes over the measured time, and provides demo video and animation images for clear explanation and communication of the delivery process to the mothers.

BiometryAssist and LaborAssist are expected to simplify the user’s workflow by not only reducing simple repetitive manual tasks, but also increasing measurement accuracy and providing consistent measurements.

These two features have been developed by incorporating the Intel Distribution of the OpenVINO toolkit into Samsung’s diagnostic algorithm. By using the OpenVINO toolkit, powered by Intel processors, data processing moves at a speed 4.7 times faster than equipment without the OpenVINO enhancements.²

“Our Intelligent Assist solutions enhance patient comfort and clinician’s convenience, reduce scan time, improve diagnosis accuracy, and increase system throughput. Samsung will continue to develop the next-generation ultrasound solutions in collaboration with Intel for the ongoing development of Intelligent Assist solutions,” announced Won-Chul Bang, Vice President of Health & Medical Equipment Business, Samsung Electronics and Samsung Medison.

The event also includes three rounds of webinars, during which world prominent OB/GYN specialists will share the clinical results of various diagnostic tools, including MV-Flow, LumiFlow and CrystalVue, which are available in the HERA series.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Intel, the Intel logo, and OpenVINO are trademarks of Intel Corporation or its subsidiaries.

The screen that automatically recognizes and annotates the heart on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

The screen that automatically recognizes the heart and displays measured values on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

¹ 510(k) pending at FDA

² Source: Internal Samsung testing.
System configuration: Intel Core i3-4100Q CPU @ 2.4 GHz, 8 GB memory; OS: 64-bit Windows 10.
Inference time without OpenVINO enhancements was 480 milliseconds. Inference time with OpenVINO enhancements was 85 milliseconds.